Guangdong, China

Shanglin Li

This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen in Vivo Biomedicine Technology Limited Company. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shanglin Li. Retrieved from https://idiyas.com/inventor/shanglin-li-uvdelkrr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shanglin Li

Introduction: Shanglin Li is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biomedicine, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a valuable asset in the scientific community.

Latest Patents: Shanglin Li holds a patent titled "Chimeric Antigen Receptor for Recognizing FC Fragment and Application Thereof." This patent showcases his innovative approach to enhancing therapeutic strategies in biomedicine. With 1 patent to his name, he continues to push the boundaries of scientific discovery.

Career Highlights: Li is currently employed at Shenzhen in Vivo Biomedicine Technology Limited Company. His role at the company allows him to collaborate with other talented professionals in the field. His work focuses on developing advanced biomedical technologies that have the potential to improve patient outcomes.

Collaborations: Shanglin Li has worked alongside notable colleagues, including Yuanbin Cui and Peng Li. Their combined expertise fosters a collaborative environment that drives innovation and research excellence.

Conclusion: Shanglin Li's contributions to the field of biomedicine through his patent and collaborative efforts highlight his commitment to advancing scientific knowledge. His work continues to inspire future innovations in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…